☆ 4.5 Letter

Reply to: appropriate dosing of burosumab in tumor-induced osteomalacia

OSTEOPOROSIS INTERNATIONAL (2022)

Get Full Text
Add to Collection

Journal

OSTEOPOROSIS INTERNATIONAL
Volume -, Issue -, Pages -

Publisher

SPRINGER LONDON LTD
DOI: 10.1007/s00198-022-06618-1

Keywords

-

Categories

Endocrinology & Metabolism

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.